Unusual Option Activity in Spectrum Pharmaceuticals

Spectrum Pharmaceuticals

has traded over 4,600 puts versus total call activity of only 600. In particular, the November 11 puts have traded 1112 contracts pushing implied volatility from 70 to 79. Spectrum Pharma is working on a Phase 2 trial of Belinstat for treatment of T-cell lymphoma.